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A flow cytometric method for the si- 
multaneous quantification and immu- 
nophenotyping of conjugates formed by 
human peripheral blood lymphocytes 
(PBL) and K562 cells has been developed. 
The method uses three fluorescent 
probes. One of the fluorescent probes (F- 
18) is used for labeling of PBL prior to 
incubation with K562 cells. After incuba- 
tion the cells are treated with monoclonal 
antibodies labeled with phycoerythrin 
and Red613, respectively. The combina- 
tion of F-18 fluorescence and light scat- 
tering signals enables identification and 
quantification of the conjugates while the 
fluorescence of the monoclonal antibod- 
ies provides information about the phe- 
notype of the conjugate forming cells. 
Results obtained using different mono- 
clonal antibodies are presented. The 
highest conjugate forming capacity has 
been found in the CD56 + CD8 + popula- 
tion while the CD4+CD8- population 
has shown the lowest capacity to form 
conjugates. The influence of a washing 
step on the conjugate formation is dis- 
cussed. The possibility to use the method 
in combination with a cytotoxicity assay 
is indicated. o 1993 Wiley-Liss, Inc. 
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Natural killer (NK) cells represent a heterogeneous 
cell population that is able to destroy, in MHC-nonre- 
stricted manner and without previous sensitization, 
different invaders of the body integrity (22). Their 
functional capability is usually assessed by cell medi- 
ated cytotoxicity assays, wherein the target cell death 
is used as a measure of the NK activity (4,12,14, 
17,18,25). 
The capability of a cytotoxic cell to form a conjugate 
with a target cell is a prerequisite for the killing pro- 
cess to take place (3,5). The detection and quantifica- 
tion of conjugates have therefore been points of inter- 
est, resulting in the development of several flow 
cytometric techniques (2,6,11,13,20,26). The finding 
that distinct populations of peripheral blood cells can 
form conjugates with the NK-sensitive targets 
(10,15,16,19,24) made determination of the phenotype 
of the conjugate forming cells problematic. The conju- 
gate identification techniques developed so far do not 
enable a direct characterization of conjugate forming 
cells but rather demand sorting, either prior to conju- 
gate formation (enrichment for certain cell types) (20) 
or after conjugates have been detected (immunopheno- 
typing of the conjugates). An exception is the work of 
Vitale et al. (26) wherein the conjugates formed by cer- 
tain lymphocyte subpopulation (identified by means of 
monoclonal antibodies) and K562 cells could be de- 
tected. However, the conjugates that unlabeled lym- 
phocyte subpopulations formed with K562 cells could 
not be resolved. 
Here we report a three fluorescent probe technique 
that enables detection of all conjugates in combination 
with characterization of the conjugate forming cells us- 
ing two monoclonal antibodies. PBL are labeled with 
the membrane probe F-18 (7,9,14) prior to incubation 
with K562 cells. After incubation the cells are stained 
with two monoclonal antibodies, labeled with phyco- 
erythrin and Red613, respectively. The conjugates 
formed by F-18-labeled PBL and K562 cells can be 
identified as F-18 positive cells with large scattering 
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signals while the monoclonal antibodies fluorescence 
enables further characterization of the conjugate form- 
ing cells. 
MATERIALS AND METHODS 
Cells 
K562 cells were used as target cells for conjugate 
formation. Cells were grown as previously described 
(14). Mononuclear cells were isolated from the heparin- 
ized peripheral blood of healthy donors as described 
elsewhere (21). The monocytes were depleted by incu- 
bating the cells (106/ml RPMI1640 + Hepes + 10% 
fetal calf serum + 2 mM L-glutamine + antibiotics 
[ 100 IU penicillin-G + 100 pg streptomycin-sulfate! 
ml], further referred to as a complete medium, CM) in 
a plastic flask for 60’ a t  37°C. Non-adherent mononu- 
clear cells were collected. 
F-18 Staining 
F-18 was prepared as  previously described (7). The 
mononuclear cell fraction was incubated with the dye 
(final concentration 10-25 ng/ml) simultaneously with 
monocytes depletion, followed by additional incubation 
of PBL for 30’ a t  37°C. Simultaneous monocyte deple- 
tion and F-18 staining resulted in similar staining as 
the subsequent incubations and it was therefore chosen 
as a more convenient method. After incubation cells 
were washed twice with cold CM and resuspended in 
CM a t  a concentration of 2 x 106/ml. 
Conjugate Formation and Labeling With 
Monoclonal Antibodies 
Monoclonal antibodies were purchased from Becton 
Dickinson (Mountain View, CA). They included anti- 
CD3-PE, anti-CD4-PE) anti-CD16-PE, anti-CD56-PE, 
anti-CD8-biotin, and anti-CD3. Streptavidin-Red613 
was purchased from Life Technologies, Inc. (Gaithers- 
burg, MD). 
K562 cell were mixed with F-18 labeled PBL in a 
ratio 1:l.  Usually a total of 5 x lo5 cells was used. The 
conjugate forming mixture was centrifuged for 5 min at 
2OOg, gently resuspended, and incubated for 20 min at 
room temperature. After incubation the cells were 
washed once with cold PBS + 1% BSA, resuspended in 
100 pl of cold PBS + 3% BSA, and incubated with 3 pl 
of monoclonal antibody (except for anti-CD56-PE 
where 10 pl was used) for 30’ at 4°C. For double stain- 
ing, 3 p1 of both PE and biotin labeled monoclonal an- 
tibodies was used. After incubation the cells were 
washed twice with cold PBS + 1% BSA and resus- 
pended in 100 pl of cold PBS + 3% BSA. Four micro- 
liters of streptavidin-Red613 was added to all samples 
containing anti-CD8-biotin and the samples were incu- 
bated for 30’ a t  4°C. The samples that did not contain 
biotin labeled monoclonal antibody were incubated in 
the same way but without addition of streptavidin- 
Red613. After incubation the samples were washed 
with cold PBS + 1% BSA, resuspended in cold PBS, 
and kept at 4°C until analyzed by flow cytometry. The 
control samples (without monoclonal antibody label- 
ing) were incubated in the same way but without ad- 
dition of monoclonal antibody and streptavidin- 
Red613. 
In the experiments where the influence of a washing 
step on conjugate formation was studied, anti-CD3 and 
anti-CD8-biotin were used. The cells were incubated 
with or without monoclonal antibodies for 30’ at 4°C 
and analyzed before and after one washing step. 
Flow Cytometer 
Experiments were performed with a home built flow 
cytometer equipped with an  argon ion laser (model 
2020, Spectra-Physics, Mountain View, CA) tuned to 
488 nm. The instrument is comparable to commercially 
available instruments and has been described else- 
where (21). F-18 fluorescence was measured using the 
green fluorescence channel (510-550 nm), PE fluores- 
cence was measured using the orange fluorescence 
channel (550-580 nm) and Red613 fluorescence was 
measured using the red fluorescence channel (> 610 
nm) . 
From each sample 16,000 cells were measured three 
times: without gating, gated on the F-18 fluorescence 
(to measure PBL and conjugates containing PBL), and 
gated on the F-18 fluorescence + forward light scat- 
tering signal (to measure exclusively conjugates). Pre- 
sented results are averages of these measurements (to- 
tal 48,000 cells). Twice as many cells were measured in 
the experiments where the influence of the washing 
step on conjugate formation was studied. 
RESULTS 
Identification of Cell Populations 
Conjugates formed by F-18 labeled PBL and K562 
cells could easily be distinguished from the single cells 
on the basis of F-18 fluorescence and light scattering 
signals (Fig. la). Cells with relatively small scattering 
signals and positive for the F-18 fluorescence are PBL 
whereas nonf luorescent cells with relatively large 
scattering signals are K562 cells. Conjugates formed 
between PBL and K562 cells are positive for F-18 flu- 
orescence and they exhibit large scattering signals. Ad- 
dition of two monoclonal antibodies, labeled with phy- 
coerythrin and Red613, respectively, enabled further 
division of the cells in different subtypes. This could be 
done for non-conjugated PBL (Fig. lb)  as well as for 
conjugated PBL (Fig. lc). 
Phenotypic Distribution 
The method enabled the analysis of the phenotypic 
distribution of conjugated PBL. The results obtained 
using a number of monoclonal antibodies identifying 
NK cell and T cells are shown in Table 1. The relative 
occurrence of the specific subpopulations in the con- 
trol (PBL incubated without K562 cells) is listed in 
column A. In columns B and C the phenotypical char- 
acteristics of the unbound and bound (conjugated) PBL 
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FIG. 1. Scatter plots showing identification of cell populations. F-18 labeled PBL were incubated with 
K562 cells to form conjugates and the sample was stained with monoclonal antibodies (anti-CD3-PE + 
anti-CD8-biotidstreptavidin-Red613). Single cells and conjugates were identified on the basis of F-18 
fluorescence and light scattering signal (a). Phenotypic identification could be done for both non-conju- 
gated PBL (b) and conjugated PBL (c). In each plot 2,500 cells are shown. 
in the conjugate forming mixture are shown. In column 
D the relative occurrence of the specific subtypes of all 
PBL in the conjugate forming mixture is shown. All 
monoclonal antibodies used for double labeling were 
also tested separately (one monoclonal antibody label- 
ing). As can be seen from the columns A and D, similar 
phenotypical distribution was obtained for control 
PBL and total PBL in the conjugate forming mixture. 
A comparison between the free and bound PBL in 
the conjugate forming mixture (columns B and C, 
respectively) revealed the preference of some cell 
types (CD3 + CD8 + ; CD4-CD8 + ; CD4 + CD8 + ; 
CD16-CD8 + ; CD56-CD8 + ; CD56 + CD8 + 1 for con- 
jugate formation. This can be seen more clearly in 
Figure 2 where the percentage of a subpopulation 
that forms a conjugate (“the conjugate forming capac- 
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Table 1 
Phenotypic Distribution" 
Control sample Conjugate forming mixture 
B C 
A (per 100 (per 100 D 
(per 100 PBL) unbound PBL) bound PBL) (per 100 PBL) 
CD3 + 64.5 t 9.9 57.6 2 4.3 72.8 t 11.4 60.8 t 7.1 
CD4 + 38.9 t 8.2 37.1 t 10.5 42.6 f 0.1 37.9 t 8.6 
CD8 + 23.8 t 5.7 9.9 t 2.2 56.5 ? 11.9 20.5 t 4.6 
CD16 + 5.4 t 0.1 2.3 ? 0.8 12.3 4 0.6 3.8 4 1.3 
CD56 + 0.7 ? 0.3 0.6 t 0.1 7.2 4 2.9 1.7 4 1.0 
CD3-CD8- 32.7 t 9.7 44.9 t 9.7 23.5 2 11.0 38.3 2 5.0 
CD3 + CD8 - 42.9 k 6.5 45.5 t 5.6 27.2 4 4.3 39.6 4 5.3 
CD3 - CD8 + 3.6 t 2.1 1.5 2 0.4 1.6 2 0.6 1.4 ? 0.5 
20.8 t 5.8 CD3 + CD8 + 20.9 2 7.7 8.2 ? 1.4 47.8 4 11.1 
CD4-CD8- 41.8 4 6.2 46.5 t 7.4 40.2 4 13.3 45.4 t 3.4 
CD4 + CD8- 37.6 k 7.6 42.2 4 11.4 15.7 * 3.5 36.5 ? 8.9 
15.7 f 4.8 CD4-CD8+ 18.9 k 1.1 10.4 2 3.6 37.6 -t- 14.7 
CD4 + CD8 + 1.8 t 0.2 1.1 2 0.4 6.5 ? 2.1 2.6 f 0.4 
CD16 -CD8- 72.0 k 2.7 84.3 2 5.4 46.6 2 10.6 77.4 ? 5.7 
CD16 + CD8- 6.2 t 0.4 3.9 k 1.9 7.7 & 1.3 4.8 2 1.0 
CD16-CD8+ 18.4 t 3.4 11.2 t 3.7 42.5 t 12.9 16.5 t_ 4.7 
CD16 + CD8 + 3.5 t 0.4 0.7 * 0.3 3.3 -t- 1.0 1.5 * 0.3 
CD56-CD8- 70.0 t 1.7 87.4 ? 0.4 35.8 & 5.6 74.5 4 2.0 
CD56 + CD8- 0.7 t 0.4 0.6 & 0.4 1.4 -t- 0.4 1.1 * 0.6 
CD56-CD8+ 29.2 k 1.2 11.9 2 0.6 60.3 2 6.1 23.2 ? 1.0 
CD56 + CD8 + 0.2 t 0.1 0.3 f 0.1 2.7 t 0.1 1.3 t 0.7 
aColumns A and D show the relative occurrence of the specific subtypes of all PBL in control sample (incubated without K562 
cells) and in the conjugate forming mixture, respectively. Columns B and C show the phenotypic characteristics, respectively, 
of the unbound and bound PBL in the conjugate forming mixture. Data are expressed as means f S.D. of 4 subjects (anti-CD3, 
anti-CD8, anti-CD3 + anti-CD8) or of 2 subjects (rest). 
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FIG. 2. Conjugate forming capacity of different PBL subpopulations. Different PBL subpopulations in 
a conjugate forming mixture were identified by double labeling with monoclonal antibodies. The per- 
centage of a subpopulation that forms a conjugate was calculated. Data are expressed as means +- S.D. 
of 4 subjects (anti-CD3 + anti-CD8) or of 2 subjects (rest). 
ity") is presented for different subpopulations. The CD16 + CD8 + and CD56-CD8 + PBL subpopulations 
highest conjugate forming capacity was exhibited showed a high conjugate forming capacity while 
by CD56+CD8+, PBL while CD4+CD8- PBL had CD3-CD8-, CD4-CD8-, CD16-CD8-, as well as 
the lowest capacity. CD3 + CD8 + , CD4 + CD8 + , CD56-CD8-, had a low conjugate forming capacity. 
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FIG. 3. Influence of washing step on conjugate formation. The per- 
centage of PBL that forms a conjugate in the samples incubated with 
monoclonal antibodies and the control sample (incubated without 
monoclonal antibodies) before and after washing step was calculated. 
Data were normalized against the number of conjugates in control 
samples before washing step (“NONE). Data are expressed as means 
? S.D. of 2 subjects. 
Influence of Washing Step on 
Conjugate Formation 
A detailed analysis of our data revealed a difference 
in the number of conjugates between samples incu- 
bated with monoclonal antibodies and the control sam- 
ple (incubated without monoclonal antibodies) that 
was only observed if the cells were washed upon incu- 
bation (Fig. 3). A washing step caused an increase in 
the number of conjugates even in the absence of mono- 
clonal antibodies (Fig. 3). A cumulative effect was 
found for anti-CD3 and anti-CD8 (Fig. 3). These results 
seem to indicate the activation of the conjugate form- 
ing ability of specific PBL subtypes but that conjugates 
are actually formed only if the cells are brought into 
close contact with target cell by centrifugation. Our 
results, however, do not exclude the possibility that Fc 
receptors present on K562 cells (8) play a role in the 
conjugate formation (1,231. 
DISCUSSION 
NK cells can be defined as a heterogeneous cell pop- 
ulation able to kill tumor cells, immature cells, and 
virus-infected cells in vitro without prior sensitization 
or MHC-restriction (22). A first, necessary step in the 
killing process is the conjugate formation between a 
killer and a target cell (33). 
In this study we have developed a three fluorescent 
probes flow cytometric assay that enables both quan- 
tification of all conjugates formed by human PBL and 
K562 cells and determination of the phenotypic char- 
acteristics of all conjugate forming cells. 
In order to test our method we have done a series of 
experiments using monoclonal antibodies that identify 
NK cells (anti-CD16, anti-CD56) and T lymphocytes 
(anti-CD3), both cytotoxic (anti-CD8) and helper cells 
(anti-CD4). 
In agreement with the expectation, our results 
show that CD8+ PBL, including CD3+CD8+, 
CD56-CD8 + , and CD56 + CD8 + , are predominant 
among the cells that form conjugates with K562 cells 
(Table 1). These PBL subtypes include both NK cells 
(CD56 + ) and cytotoxic lymphocytes (CD3 + 1. AS 
expected, CD3-CD8- (mostly B lymphocytes), 
CD4+ CD8- (T helper lymphocytes), CD16-CD8 - 
and CD56-CD8- (B lymphocytes, T helper lympho- 
cytes) cells subtypes are predominant among unbound 
PBL. Analysis of the conjugate forming capacity (e.g., 
the percentage of a subpopulation that forms a conju- 
gate) of PBL subtypes reveals the CD56+CD8+ 
(mostly NK cells) population as the cell type with the 
highest conjugate forming capacity (Fig. 2). Another 
subtype consisting mostly of the NK cells, the 
CD16 + CD8 + population, shows also a high conjugate 
forming capacity while subtypes consisting mostly 
of T helper and B lymphocytes (CD4+CD8-, 
CD3,4,16,56-CD8-1 have a low conjugate forming 
capacity. 
An unexpected finding in our study is that labeling 
with monoclonal antibodies after the cells were incu- 
bated to form conjugates influences the conjugate for- 
mation. We found that this was due to the extra wash- 
ing step (Fig. 3). Even without addition of monoclonal 
antibodies the washing step causes a significant in- 
crease in the number of conjugates. An even larger 
increase is observed if the cells are incubated with anti- 
CD3 and anti-CD8 that also show a cumulative effect 
(Fig. 3). These results could indicate that certain mono- 
clonal antibodies can activate the conjugate formation 
but that the effect is observed only when the cells are 
brought into contact with target cells by additional 
centrifugation (washing). A possible involvement of 
the K562 cell Fc receptors (8) in the conjugate forma- 
tion (1,231 is, however, not excluded. 
The influence of the washing step on the conjugate 
formation can be avoided using directly labeled mono- 
clonal antibodies (no washing step needed!) instead of 
indirect labeling. 
There are at least two possibilities to combine this 
assay (identification of the conjugates and immunophe- 
notyping) with a cytotoxicity assay. In the first case 
changes in the light scattering characteristics of a tar- 
get cell could be used as the indicator of target cell 
death (25). Another possibility would be to use propid- 
ium iodide as target cell indicator. In this case only one 
monoclonal antibody could be used. With such a com- 
bined assay one could follow the kinetics of the cyto- 
toxic process of different cell types. 
In conclusion, our study demonstrates the possibility 
to identify and quantify conjugates simultaneously 
with immunophenotyping of the conjugate forming 
cells. 
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